CN Patent

CN114173789A — 用于治疗由生殖支原体引起的感染的组合

Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2022-03-11 · 4y expired

What this patent protects

本发明涉及用于治疗由生殖支原体引起或与之相关的细菌感染的方法，该方法包括向需要的人施用gepotidacin或其药学上可接受的盐和多西环素。还公开了新的药物组合、组合物、耐药指导疗法和/或其相应用途。

USPTO Abstract

本发明涉及用于治疗由生殖支原体引起或与之相关的细菌感染的方法，该方法包括向需要的人施用gepotidacin或其药学上可接受的盐和多西环素。还公开了新的药物组合、组合物、耐药指导疗法和/或其相应用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN114173789A
Jurisdiction: CN
Classification: —
Expires: 2022-03-11
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline Intellectual Property Development Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.